tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
H.C. Wainwright downgrades Kala Bio to Neutral after CHASE trial miss
PremiumThe FlyH.C. Wainwright downgrades Kala Bio to Neutral after CHASE trial miss
1M ago
Kala Bio shared no details on study miss, says Mizuho
Premium
The Fly
Kala Bio shared no details on study miss, says Mizuho
1M ago
Kala Pharmaceuticals downgraded to Market Perform at LifeSci Capital
Premium
The Fly
Kala Pharmaceuticals downgraded to Market Perform at LifeSci Capital
1M ago
Kala says CHASE Phase 2b KPI-012 trial did not meet primary endpoint
PremiumThe FlyKala says CHASE Phase 2b KPI-012 trial did not meet primary endpoint
1M ago
Kala Pharmaceuticals Sets Date for Annual Meeting
Premium
Company Announcements
Kala Pharmaceuticals Sets Date for Annual Meeting
2M ago
Strategic Positioning and Trial Design Propel Kala Pharmaceuticals to ‘Buy’ Rating
Premium
Ratings
Strategic Positioning and Trial Design Propel Kala Pharmaceuticals to ‘Buy’ Rating
2M ago
Kala Pharmaceuticals initiated with an Outperform at LifeSci Capital
PremiumThe FlyKala Pharmaceuticals initiated with an Outperform at LifeSci Capital
2M ago
Kala Pharmaceuticals Appoints Todd Bazemore as CEO
Premium
Company Announcements
Kala Pharmaceuticals Appoints Todd Bazemore as CEO
2M ago
Kala Bio appoints Bazemore as President, CEO, Director
Premium
The Fly
Kala Bio appoints Bazemore as President, CEO, Director
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100